Ligand validation:4OTJ

IXP: (5S,5aS,8aS,9S)-8-oxo-9-(3,4,5-trimethoxyphenyl)-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4-{[4-({[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetyl}amino)butyl]amino}-4-oxobutanoate

IXP is a Ligand Of Interest in 4OTJ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4OTJ_IXP_C_706	47%	9%	0.138	0.877	2.51	2.04	14	25	6	0	100%	0.3788
4OTJ_IXP_A_706	46%	10%	0.151	0.885	2.45	1.88	14	18	3	0	100%	0.4848
4OTJ_IXP_B_707	41%	10%	0.168	0.884	2.41	1.9	14	18	9	0	100%	0.4236
4OTJ_IXP_D_707	22%	10%	0.206	0.821	2.43	1.85	13	16	10	0	100%	0.4848

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.